Education
About Us
Working with TipRanks
Follow Us
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (GZPHF)
OTHER OTC:GZPHF
RESEARCH TOOLSreports
Total Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of $5.77B. The enterprise value is ―.
Market Cap$5.77B
Enterprise Value―
Share Statistics
Guangzhou Baiyunshan Pharmaceutical Holdings Company has 219,900,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,900,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Guangzhou Baiyunshan Pharmaceutical Holdings Company’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.76%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.76%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee2.67M
Profits Per Employee106.64K
Employee Count28,138
Asset Turnover0.92
Inventory Turnover4.88
Valuation Ratios
The current PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company is 9.80. Guangzhou Baiyunshan Pharmaceutical Holdings Company’s PEG ratio is -1.12.
PE Ratio9.80
PS Ratio0.00
PB Ratio0.68
Price to Fair Value0.77
Price to FCF112.49
Price to Operating Cash Flow23.40
PEG Ratio-1.12
Income Statement
In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 74.99B and earned 2.84B in profits. Earnings per share was 1.74.
Revenue74.99B
Gross Profit12.52B
Operating Income3.60B
Pretax Income3.61B
Net Income2.84B
EBITDA4.90B
Earnings Per Share (EPS)1.74
Cash Flow
In the last 12 months, operating cash flow was 1.10B and capital expenditures 0.00, giving a free cash flow of 4.73B billion.
Operating Cash Flow1.10B
Free Cash Flow4.73B
Free Cash Flow per Share21.52
Dividends & Yields
Guangzhou Baiyunshan Pharmaceutical Holdings Company pays an annual dividend of $0.056, resulting in a dividend yield of 7.36%
Dividend Per Share$0.056
Dividend Yield7.36%
Payout Ratio45.69%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change-25.68%
50-Day Moving Average2.36
200-Day Moving Average2.36
Relative Strength Index (RSI)20.92
Average Volume (3m)196.00
Important Dates
Guangzhou Baiyunshan Pharmaceutical Holdings Company upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend DateOct 15, 2024
Financial Position
Guangzhou Baiyunshan Pharmaceutical Holdings Company as a current ratio of 1.48, with Debt / Equity ratio of 30.61%
Current Ratio1.48
Quick Ratio1.16
Debt to Market Cap0.43
Net Debt to EBITDA-1.20
Interest Coverage Ratio8.60
Taxes
In the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company has paid 606.85M in taxes.
Income Tax606.85M
Effective Tax Rate0.17
Enterprise Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Company EV to EBITDA ratio is 4.47, with an EV/FCF ratio of 9.46.
EV to Sales0.29
EV to EBITDA4.47
EV to Free Cash Flow9.46
EV to Operating Cash Flow6.36
Balance Sheet
Guangzhou Baiyunshan Pharmaceutical Holdings Company has $14.51B in cash and marketable securities with ¥11.55B in debt, giving a net cash position of -$2.96B billion.
Cash & Marketable Securities$14.51B
Total Debt¥11.55B
Net Cash-$2.96B
Net Cash Per Share-$13.48
Tangible Book Value Per Share$20.75
Margins
Gross margin is 16.17%, with operating margin of 4.80%, and net profit margin of 3.78%.
Gross Margin16.17%
Operating Margin4.80%
Pretax Margin4.81%
Net Profit Margin3.78%
EBITDA Margin6.54%
EBIT Margin5.37%
Analyst Forecast
The average price target for Guangzhou Baiyunshan Pharmaceutical Holdings Company is $2.06, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$2.06
Price Target Upside-6.36% Downside
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―